Silvio Ligia
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.
Journal: Annals of hematology
Published: January 30, 2026
A case report of high-titer FVIII inhibitor development after AAV-mediated gene therapy in hemophilia A.
Journal: Blood vessels, thrombosis & hemostasis
Published: January 09, 2026
Perioperative Outcomes in Factor XI Deficiency: A Systematic Review.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 06, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.
Journal: British journal of haematology
Published: November 16, 2025
A Long Misdiagnosed MYH9-Related Disease With Both Bleeding and Thrombotic Manifestations: A Case Report.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 18, 2025
Severe hemophilia A with inhibitors and pancreatic cancer - when emicizumab is not enough.
Journal: Blood transfusion = Trasfusione del sangue
Published: September 13, 2025
Severe Hemophilia A and Congenital Antithrombin Deficiency: A Case of Natural Hemostatic Rebalancing.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 23, 2025
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients.
Journal: Mediterranean journal of hematology and infectious diseases
Published: February 06, 2025
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.
Journal: HemaSphere
Published: February 04, 2025
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers.
Journal: Annals of hematology
Published: February 15, 2024
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report.
Journal: Frontiers in oncology
Published: November 14, 2023
Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome.
Journal: British journal of haematology
Published: September 07, 2023
Last Updated: 09/26/2026